Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), announced today the establishment of a Scientific Advisory Board (SAB) of renowned experts in their respective fields to provide scientific and clinical guidance on the development of Affimed’s innate cell engagers (ICE®) programs.
June 30, 2022
· 3 min read